A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults with Type-1 Diabetes Mellitus
NCT06097689 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2024-10-01
Summary
The primary aim of this study is to assess the feasibility of the Lab demo 1.0 and associated computational models to detect and track glucose changes noninvasively and transcutaneously in defined and dynamic states of glycemia.
Conditions
- Type 1 Diabetes Mellitus
- Type 1 Diabetes Mellitus with Hypoglycemia
- Type 1 Diabetes Mellitus with Hyperglycemia
Interventions
- DEVICE
-
Lab Demo 1.0
Lowering of the participants blood glucose with the application of insulin to induce hypoglycaemia, followed by the application of glucose to induce hyperglycaemia and finally insulin to restore euglycemia. During the different glycaemia states, transcutaneous spectral data are collected continuously with the device and paired with reference measurements (venous blood and interstitial fluid).
Sponsors & Collaborators
-
DCB Research AG
collaborator OTHER -
Liom Health AG
lead INDUSTRY
Principal Investigators
-
Fabien Rebeaud, PhD · Liom Health AG
-
Markus Laimer, Prof Dr med · University Department of Diabetology, Endocrinology, Nutritional Medicine & Metabolism (UDEM), Inselspital, Bern University Hospital
Study Design
- Allocation
- NA
- Purpose
- DEVICE_FEASIBILITY
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-11-24
- Primary Completion
- 2024-05-16
- Completion
- 2024-05-16
Countries
- Switzerland
Study Locations
More Related Trials
-
Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research Setting
NCT01401751 ·Status: COMPLETED ·Phase: NA
-
Real-time Adaptation to Changes in Insulin Sensitivity
NCT01261052 ·Status: COMPLETED ·Phase: PHASE2
-
The isCGM Use and Hypoglycemic Episodes and Fear of Hypoglycemia in Newly Diagnosed Type 1 Diabetes
NCT06414824 ·Status: TERMINATED ·Phase: NA
-
Glucose Counterregulation in Long Standing Type 1 Diabetes
NCT01474889 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Novel Method for Integrating Insulin Delivery and Glucose Sensing in Adipose Tissue of Diabetic Patients
NCT00813410 ·Status: COMPLETED ·Phase: NA
-
Prevention of Severe Hypoglycemia in Type 1 Diabetes
NCT00360984 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes
NCT02068638 ·Status: COMPLETED ·Phase: NA
-
New Glucose Sensor Pediatric
NCT01161043 ·Status: COMPLETED ·Phase: NA
-
Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis
NCT07087340 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) Therapy
NCT01104142 ·Status: COMPLETED
-
Mobile Insulin Titration Intervention
NCT01879579 ·Status: COMPLETED ·Phase: NA
-
Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes
NCT01713348 ·Status: COMPLETED ·Phase: PHASE4
-
YpsoPump Occlusion Detection Algorithm: Collection of Real-world Data for In-silico Evaluation of a New Software Algorithm to Refine Occlusion Detection in Subjects With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
NCT05096325 ·Status: COMPLETED
-
Validation of a Biomathematical Model to Help Identify the Parameters of Flexible Insulin Therapy
NCT04572009 ·Status: COMPLETED ·Phase: NA
-
Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software
NCT00552734 ·Status: COMPLETED
-
CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections
NCT02092051 ·Status: COMPLETED ·Phase: NA
-
Insulin Titration System Based on Deep Learning
NCT05409391 ·Status: COMPLETED ·Phase: NA
-
Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM
NCT02558491 ·Status: COMPLETED ·Phase: NA
-
CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D)
NCT03263494 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Objective Sleep Duration on Blood Glucose Control in Type 1 Diabetes Adult Patients
NCT01017965 ·Status: TERMINATED
-
The Steno Free Trial: AID to Adults with New-onset of Type 1 Diabetes
NCT06586632 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes Mellitus
NCT01185496 ·Status: COMPLETED
-
Feasibility of Using the CGM During TOC From in Persons With T2D Using Insulin
NCT04533945 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration
NCT02359617 ·Status: COMPLETED ·Phase: NA
-
Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes
NCT00922649 ·Status: COMPLETED ·Phase: NA